News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
444,242 Results
Type
Article (19813)
Company Profile (151)
Press Release (424268)
Multimedia
Podcasts (58)
Webinars (13)
Section
Business (130013)
Career Advice (625)
Deals (20726)
Drug Delivery (54)
Drug Development (43730)
Employer Resources (71)
FDA (10063)
Job Trends (9276)
News (206039)
Policy (15433)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (1792)
Accelerated approval (14)
Adcomms (4)
Allergies (95)
Alliances (38301)
ALS (89)
Alzheimer's disease (1009)
Antibody-drug conjugate (ADC) (201)
Approvals (10302)
Artificial intelligence (486)
Autoimmune disease (86)
Automation (33)
Bankruptcy (146)
Best Places to Work (7820)
BIOSECURE Act (8)
Biosimilars (69)
Biotechnology (109)
Bladder cancer (78)
Brain cancer (35)
Breast cancer (373)
Cancer (2956)
Cardiovascular disease (275)
Career advice (568)
Career pathing (19)
CAR-T (223)
CDC (19)
Cell therapy (562)
Cervical cancer (25)
Clinical research (36549)
Collaboration (1397)
Compensation (303)
Complete response letters (13)
COVID-19 (1644)
CRISPR (92)
C-suite (617)
Cystic fibrosis (92)
Data (3977)
Decentralized trials (1)
Denatured (28)
Depression (68)
Diabetes (307)
Diagnostics (5584)
Digital health (37)
Diversity (7)
Diversity, equity & inclusion (16)
Drug discovery (195)
Drug pricing (31)
Drug shortages (6)
Duchenne muscular dystrophy (124)
Earnings (46505)
Editorial (19)
Employer branding (11)
Employer resources (65)
Events (66182)
Executive appointments (706)
FDA (12061)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (6)
Frontotemporal dementia (17)
Funding (1097)
Gene editing (187)
Generative AI (44)
Gene therapy (416)
GLP-1 (460)
Government (1880)
Grass and pollen (4)
Guidances (264)
Healthcare (11779)
HIV (41)
Huntington's disease (19)
IgA nephropathy (46)
Immunology and inflammation (98)
Immuno-oncology (28)
Indications (66)
Infectious disease (1820)
Inflammatory bowel disease (121)
Inflation Reduction Act (5)
Influenza (85)
Intellectual property (171)
Interviews (79)
IPO (9100)
IRA (15)
Job creations (1780)
Job search strategy (493)
JPM (32)
Kidney cancer (8)
Labor market (38)
Layoffs (200)
Leadership (13)
Legal (3075)
Liver cancer (53)
Longevity (9)
Lung cancer (359)
Lymphoma (223)
Machine learning (39)
Management (26)
Manufacturing (578)
MASH (78)
Medical device (12228)
Medtech (12278)
Mergers & acquisitions (12345)
Metabolic disorders (656)
Multiple sclerosis (93)
NASH (6)
Neurodegenerative disease (187)
Neuropsychiatric disorders (37)
Neuroscience (1707)
Neurotech (1)
NextGen: Class of 2026 (4069)
Non-profit (2421)
Now hiring (27)
Obesity (258)
Opinion (133)
Ovarian cancer (109)
Pain (135)
Pancreatic cancer (135)
Parkinson's disease (184)
Partnered (24)
Patents (336)
Patient recruitment (306)
Peanut (39)
People (41521)
Pharmaceutical (22)
Pharmacy benefit managers (3)
Phase 1 (12408)
Phase 2 (16031)
Phase 3 (11501)
Pipeline (3317)
Policy (104)
Postmarket research (1008)
Preclinical (6103)
Press Release (68)
Prostate cancer (145)
Psychedelics (21)
Radiopharmaceuticals (199)
Rare diseases (458)
Real estate (3841)
Recruiting (31)
Regulatory (12895)
Reports (22)
Research institute (1835)
Resumes & cover letters (90)
Rett syndrome (25)
RNA editing (10)
RSV (45)
Schizophrenia (57)
Series A (193)
Series B (123)
Service/supplier (6)
Sickle cell disease (60)
Special edition (3)
Spinal muscular atrophy (101)
Sponsored (29)
Startups (2864)
State (2)
Stomach cancer (3)
Supply chain (56)
Tariffs (15)
The Weekly (29)
Vaccines (597)
Venture capital (52)
Weight loss (115)
Women's health (56)
Worklife (4)
Date
Last 7 days (360)
Last 30 days (1259)
Last 365 days (18875)
2026 (1795)
2025 (19213)
2024 (22884)
2023 (26763)
2022 (36002)
2021 (38332)
2020 (36007)
2019 (30237)
2018 (22826)
2017 (22164)
2016 (20980)
2015 (24183)
2014 (17939)
2013 (14852)
2012 (15976)
2011 (16375)
2010 (14799)
Location
Africa (411)
Alabama (77)
Alaska (6)
Arizona (196)
Arkansas (12)
Asia (27626)
Australia (4859)
California (6932)
Canada (2053)
China (665)
Colorado (322)
Connecticut (305)
Delaware (156)
Europe (61029)
Florida (1057)
Georgia (266)
Hawaii (3)
Idaho (41)
Illinois (527)
India (35)
Indiana (313)
Iowa (8)
Japan (293)
Kansas (108)
Kentucky (19)
Louisiana (24)
Maine (68)
Maryland (847)
Massachusetts (4796)
Michigan (280)
Minnesota (451)
Mississippi (6)
Missouri (107)
Montana (28)
Nebraska (18)
Nevada (64)
New Hampshire (85)
New Jersey (1919)
New Mexico (29)
New York (1830)
North Carolina (911)
North Dakota (9)
Northern California (3306)
Ohio (220)
Oklahoma (18)
Oregon (39)
Pennsylvania (1336)
Puerto Rico (20)
Rhode Island (41)
South America (610)
South Carolina (62)
South Dakota (1)
Southern California (2725)
Tennessee (122)
Texas (1132)
United States (24992)
Utah (254)
Vermont (1)
Virginia (131)
Washington D.C. (26)
Washington State (588)
West Virginia (4)
Wisconsin (96)
Wyoming (1)
444,242 Results for "redwood scientific technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Redwood Scientific Technologies Inc.today announced a strategic shift in its product development priorities
Redwood Scientific Technologies Inc. (OTC: RSCI) (“Redwood” or “the Company”), a pharmaceutical company, today announced a strategic shift in its product development priorities.
April 18, 2024
·
2 min read
Press Releases
Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation
January 12, 2026
·
7 min read
Press Releases
TempraMed Appoints Leading Diabetes Researcher Professor Dr. Lutz Heinemann to its Scientific Advisory Board
A renowned expert in insulin pharmacology, diabetes technology, and temperature-sensitive medication stability joins TempraMed to strengthen scientific leadership
December 10, 2025
·
6 min read
Pharm Country
Redwood Scientific Technologies Inc. (RSCI.OTC.PK) Announces Successful S1 Registration Filing and Provides Updates on TBX FREE Clinical Trial Progress
Redwood Scientific Technologies is delighted to announce the successful filing of its S1 registration statement with the Securities and Exchange Commission (SEC).
September 18, 2023
·
1 min read
Press Releases
Galaxy Brain Scientific’s Technology Enables Landmark Parkinson’s Study Published in Nature, Redefining Disease Mechanism
February 5, 2026
·
2 min read
Business
Redwood Scientific Technologies Inc., Announces Partnership Agreement with Silk Road Ent., Inc., for Retail Distribution of TBX FREE and TBX VAPE FREE
Redwood Scientific Technologies Inc. (RSCI. OTC. PK) announces a partnership with Silk Road Ent., Inc. (SKRJ, OTC, PK) for retail distribution of TBX FREE and TBX VAPE FREE, its smoking cessation products.
July 19, 2023
·
1 min read
Press Releases
Integrated Biosciences Appoints Daniel J. Anderson, Ph.D. as Chief Scientific Officer
January 27, 2026
·
2 min read
Policy
Eyenovia Announces FDA Approval of Redwood City as Commercial Manufacturing Facility
Eyenovia, Inc. announced that the company’s facility in Redwood City, California successfully completed FDA inspection for approval as a commercial manufacturing facility.
February 13, 2024
·
5 min read
Press Releases
DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting
October 30, 2025
·
6 min read
Press Releases
Eurobio Scientific: 2025 FY revenue
January 28, 2026
·
4 min read
1 of 44,425
Next
